MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Meta-optimization to select stimulation settings for deep brain stimulation in Parkinson’s disease

    M. Connolly, F. Isbaine, J. Willie, R. Gross, A. Devergnas, S. Miocinovic (Atlanta, USA)

    Objective: The objective is to develop an algorithmic approach for selecting deep brain stimulation (DBS) settings for Parkinson’s disease (PD) and other movement disorders more…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • 2022 International Congress

    Clinical and Imaging features of Hyperkinetic Movement Disorders related with Stroke

    H. Valdez Ruvalcaba, H. Martinez, G. Chac Lezama, F. de Leon, H. Pacheco Mendoza, V. Cano Nigenda, L. Alvarez, A. Arauz, A. Medina-Islas (mexico, Mexico)

    Objective: To describe the characteristics of hyperkinetic movement disorders in patients with stroke. Background: Movement disorders (MD) related to cerebrovascular disease represent 22% of all…
  • 2022 International Congress

    α-Synuclein molecular behavior and proteomic profiling distinguish subtypes of Lewy body disorders

    I. Martinez-Valbuena, E. Swinkin, E. Santamaria Martinez, J. Fernandez-Irigoyen, V. Sackmann, A. Kim, P. Gonzalez-Latapi, G. Kuhlman, S. Bhowmick, NP. Visanji, AE. Lang, GG. Kovacs (Toronto, Canada)

    Objective: We hypothesized that the clinical heterogeneity found in Lewy body disorders is a consequence of the molecular diversity of αSyn between different patients as…
  • 2022 International Congress

    The effect of short-term treadmill exercise in the alpha-synuclein preformed fibril rat model of Parkinson’s disease

    S. Fleming, J. Patterson, C. Kemp, J. Lepp, E. Hamad, S. Scott, J. Holden, A. Davis, C. Szarowicz, J. Lipton, M. Kubik, N. Kuhn, A. Stoll, K. Luk, C. Sortwell (Rootstown, USA)

    Objective: To determine how treadmill exercise impacts behavior and Parkinson-related pathology in the alpha-synuclein (a-syn) preformed fibril (PFF) model. Background: Exercise is often recommended by…
  • 2022 International Congress

    Hidden effects of COVID-19 pandemic on Parkinson’s Disease: a telemedicine survey

    V. Tommasini, C. Bertolotti, M. Catalan, P. Polverino, L. Antonutti, G. Bellavita, A. Cucca, M. Liccari, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to report the telemedicine experience of our Movement Disorder Unit during COVID-19 pandemic and to assess the clinical…
  • 2022 International Congress

    Quality of life changes after subthalamic stimulation for Parkinson’s disease depend on nonmotor and motor symptoms clusters

    L. Braun, S. Jost, M. Silverdale, A. Rizos, M. Santos Ghilardi, R. Cury, P. Loehrer, C. Nimsky, K. Ashkan, A. Sauerbier, A. Gronostay, G. Fink, M. Barbe, J. Evans, V. Visser-Vandewalle, E. Fonoff, A. Antonini, L. Timmermann, P. Martinez-Martin, K. Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To analyze quality of life (QoL) changes after subthalamic stimulation (STN-DBS) based on a short list of baseline nonmotor and motor symptoms in Parkinson’s…
  • 2022 International Congress

    The role of Parkinson Nurses for personalizing care in Parkinson’s Disease: a systematic review and meta-analysis

    J. Stümpel, M. van Munster, T. Mestre, D. Pedrosa (Cologne, Germany)

    Objective: To identify the various roles and functions that Parkinson Nurses (PNs) may hold for personalized care of Patients with Parkinson’s (PwPs). Providing a systematic…
  • 2022 International Congress

    Parkin deficiency impairs mtDNA dynamics and propagates inflammation

    K. Wasner, S. Smajić, J. Ghelfi, S. Delcambre, C. Prada-Medina, E. Knappe, G. Arena, P. Mulica, G. Agyeah, A. Rakovic, I. Boussaad, K. Badanjak, J. Ohnmacht, J. Gérardy, M. Takanashi, J. Trinh, M. Mittelbronn, N. Hattori, C. Klein, P. Antony, P. Seibler, M. Spielmann, S. Pereira, A. Grünewald (Belvaux, Luxembourg)

    Objective: We sought to explore Parkin’s role in (i) averting neuronal mtDNA dyshomeostasis/release and (ii) the activation of downstream inflammatory processes. Background: Mutations in Parkin…
  • 2022 International Congress

    Gene and variant curation of Parkinson’s disease genes by an authoritative expert panel

    J. Beck, K. Lohmann, L. Lange, A. Naito, A. Kumeh, C. Thaxton, M. Weaver, S. Strom, R. Alcalay (New York, USA)

    Objective: Establish an authoritative central curation for causative genes and variants for Parkinson’s disease (PD) Background: The urgency to establish central curation for causative genes…
  • « Previous Page
  • 1
  • …
  • 666
  • 667
  • 668
  • 669
  • 670
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley